Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001

Last participant has been randomised in clinical trial 0205 investigating efficacy and safety of CT001 relative to placebo and two comparative active arms Primary aim is to show that CT001 offers a better pain reduction and safety profile compared to the comparative arms and placebo…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.